These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38914941)

  • 1. Deciphering the role of KLRB1: a novel prognostic indicator in hepatocellular carcinoma.
    Fang S; Zhou Y
    BMC Gastroenterol; 2024 Jun; 24(1):210. PubMed ID: 38914941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Novel CD8
    Li X; Qu X; Li S; Lin K; Yao N; Wang N; Shi Y
    Cancer Control; 2024; 31():10732748241270583. PubMed ID: 39152700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients.
    Chew V; Tow C; Huang C; Bard-Chapeau E; Copeland NG; Jenkins NA; Weber A; Lim KH; Toh HC; Heikenwalder M; Ng IO; Nardin A; Abastado JP
    J Natl Cancer Inst; 2012 Dec; 104(23):1796-807. PubMed ID: 23197495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma.
    Huo J; Wu L; Zang Y
    BMC Med Genomics; 2021 Sep; 14(1):232. PubMed ID: 34544391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.
    Xu N; Meng X; Chu H; Yang Z; Jiao Y; Li Y
    PeerJ; 2023; 11():e15654. PubMed ID: 37520246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High ratio of resident to exhausted CD4 + T cells predicts favorable prognosis and potentially better immunotherapeutic efficacy in hepatocellular carcinoma.
    Zuo A; Lv J; Jia W; Ba Y; Liu S; Zhang Y; Weng S; Xu H; Liu L; Wang L; Han X; Liu Z
    BMC Cancer; 2024 Sep; 24(1):1152. PubMed ID: 39289669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients.
    He JR; Li D; Zhang QX; Liu T; Ding Y; Wu CY; Chen SS; Chen JL
    Aging (Albany NY); 2023 Nov; 15(22):13265-13286. PubMed ID: 37988189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical significance of NLRC5 in hepatocellular carcinoma.
    Ma X; Ning S; Sun T; Liu M; Liu J
    Cancer Biol Ther; 2024 Dec; 25(1):2390205. PubMed ID: 39132868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.
    Cheng X; Cao Y; Wang X; Cheng L; Liu Y; Lei J; Peng W; Shi D
    J Immunol Res; 2022; 2022():5254911. PubMed ID: 35028320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD1
    Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
    J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma.
    Cui Z; Li H; Liu C; Wang J; Chen C; Hu S; Zhao X; Li G
    Aging (Albany NY); 2024 Apr; 16(7):6550-6565. PubMed ID: 38604154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADH4-a potential prognostic marker for hepatocellular carcinoma with possible immune-related implications.
    Li L; Huang YT; Wang LT; Wang XL; Chen ZY; Jiang SL; Zeng QL; Huang HP; Li XL
    BMC Cancer; 2024 Aug; 24(1):927. PubMed ID: 39090641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma.
    Fang L; Gong J; Wang Y; Liu R; Li Z; Wang Z; Zhang Y; Zhang C; Song C; Yang A; Ting JP; Jin B; Chen L
    J Exp Clin Cancer Res; 2014 Sep; 33(1):76. PubMed ID: 25228093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c.503T>C Polymorphism in the Human KLRB1 Gene Alters Ligand Binding and Inhibitory Potential of CD161 Molecules.
    Rother S; Hundrieser J; Pokoyski C; Kollrich S; Borns K; Blasczyk R; Poehnert D; Klempnauer J; Schwinzer R
    PLoS One; 2015; 10(8):e0135682. PubMed ID: 26309225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma.
    Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z
    Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma.
    Sun Y; Wu L; Zhong Y; Zhou K; Hou Y; Wang Z; Zhang Z; Xie J; Wang C; Chen D; Huang Y; Wei X; Shi Y; Zhao Z; Li Y; Guo Z; Yu Q; Xu L; Volpe G; Qiu S; Zhou J; Ward C; Sun H; Yin Y; Xu X; Wang X; Esteban MA; Yang H; Wang J; Dean M; Zhang Y; Liu S; Yang X; Fan J
    Cell; 2021 Jan; 184(2):404-421.e16. PubMed ID: 33357445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma.
    Pan L; Fang J; Chen MY; Zhai ST; Zhang B; Jiang ZY; Juengpanich S; Wang YF; Cai XJ
    World J Gastroenterol; 2020 Feb; 26(8):789-803. PubMed ID: 32148377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAC1
    Shi X; Chen W; Yin Y; Cao H; Wang X; Jiang W; Li Q; Li X; Yu Y; Wang X
    Cancer Lett; 2024 Jun; 592():216909. PubMed ID: 38679407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles.
    Wu M; Mei F; Liu W; Jiang J
    Biomed Pharmacother; 2020 Jan; 121():109637. PubMed ID: 31810126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.